Daan Gene Co., Ltd. (SHE:002030)
China · Delayed Price · Currency is CNY 5.75
+0.11 (1.95%)
Sep 30, 2026, 3:04 PM CST
Daan Gene Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 580.9 | 506.29 | 872.09 | 999.37 | 2,594 | 2,179 |
Short-Term Investments | 299.7 | 388.19 | 858.76 | 1,310 | 485.37 | - |
Trading Asset Securities | 555.73 | 593.89 | 63 | 90.08 | 480.9 | 380.01 |
Cash & Short-Term Investments | 1,436 | 1,488 | 1,794 | 2,400 | 3,561 | 2,559 |
Cash Growth | 10.46% | -17.03% | -25.25% | -32.61% | 39.15% | 45.53% |
Accounts Receivable | 781.62 | 819.23 | 1,318 | 2,170 | 4,247 | 2,352 |
Other Receivables | 22.68 | 26.34 | 33.62 | 50 | 52.76 | 56.46 |
Receivables | 870.16 | 914.08 | 1,461 | 2,353 | 4,445 | 2,525 |
Inventory | 143.74 | 147.58 | 198.21 | 239.52 | 369.6 | 493.72 |
Other Current Assets | 276.16 | 293.55 | 328.66 | 318.19 | 393.98 | 407.6 |
Total Current Assets | 2,726 | 2,844 | 3,782 | 5,310 | 8,769 | 5,985 |
Property, Plant & Equipment | 1,470 | 1,500 | 1,790 | 1,903 | 1,767 | 863.06 |
Long-Term Investments | 2,882 | 2,899 | 2,537 | 2,517 | 3,070 | 2,703 |
Other Intangible Assets | 414.92 | 418.39 | 572.72 | 279.7 | 204.12 | 115.03 |
Long-Term Accounts Receivable | 91.58 | 99.87 | 87.47 | 35.91 | 72.05 | 16.62 |
Long-Term Deferred Tax Assets | 345.11 | 344.36 | 358.39 | 228.9 | 199.34 | 112.69 |
Long-Term Deferred Charges | 241.09 | 291.23 | 397.58 | 670.48 | 574.92 | 331.52 |
Other Long-Term Assets | 85.35 | 87.54 | 34.39 | 57.21 | 99.95 | 209.08 |
Total Assets | 8,282 | 8,511 | 9,577 | 11,018 | 14,757 | 10,336 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 255.92 | 259.68 | 357.87 | 425.44 | 737.07 | 553.01 |
Accrued Expenses | 419.32 | 485.7 | 569.74 | 760.13 | 1,559 | 985.63 |
Short-Term Debt | 98.3 | 103.79 | 143.53 | 330.8 | 117.76 | 282.59 |
Current Portion of Leases | 2.82 | 3.32 | 6.95 | 13.21 | 42.66 | 45.32 |
Current Income Taxes Payable | 28.05 | 28.03 | 28.12 | 29.69 | 302 | 383.47 |
Current Unearned Revenue | 38.45 | 35.29 | 66.23 | 34.23 | 69.34 | 152.45 |
Other Current Liabilities | 77.95 | 91.57 | 121.3 | 127.58 | 140.9 | 118.58 |
Total Current Liabilities | 920.8 | 1,007 | 1,294 | 1,721 | 2,969 | 2,521 |
Long-Term Leases | 2.58 | 3.37 | 13.46 | 21.81 | 67.38 | 76.15 |
Long-Term Unearned Revenue | 33.4 | 44.94 | 58.53 | 32.69 | 27.27 | 30.14 |
Long-Term Deferred Tax Liabilities | 52.45 | 63.88 | 61.24 | 79.85 | 47.97 | 46.97 |
Other Long-Term Liabilities | 31.56 | 26.15 | 6.93 | 5.41 | 29.8 | 2.17 |
Total Liabilities | 1,041 | 1,146 | 1,434 | 1,861 | 3,141 | 2,676 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 1,403 | 1,403 | 1,403 | 1,403 | 1,403 | 1,403 |
Additional Paid-In Capital | 601.81 | 601.69 | 600.97 | 651.54 | 719.99 | 621.38 |
Retained Earnings | 5,018 | 5,139 | 5,883 | 6,829 | 9,181 | 5,326 |
Comprehensive Income & Other | -5.78 | -5.84 | -7.41 | -3.92 | -2.85 | 0.5 |
Total Common Equity | 7,018 | 7,138 | 7,880 | 8,880 | 11,301 | 7,351 |
Minority Interest | 223.14 | 226.92 | 263.07 | 276.83 | 314.79 | 308.63 |
Shareholders' Equity | 7,241 | 7,365 | 8,143 | 9,157 | 11,616 | 7,660 |
Total Liabilities & Equity | 8,282 | 8,511 | 9,577 | 11,018 | 14,757 | 10,336 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 103.7 | 110.48 | 163.94 | 365.83 | 227.8 | 404.06 |
Net Cash (Debt) | 1,333 | 1,378 | 1,630 | 2,034 | 3,333 | 2,155 |
Net Cash Growth | 10.92% | -15.46% | -19.86% | -38.98% | 54.66% | 60.03% |
Net Cash Per Share | 0.97 | 0.98 | 1.16 | 1.36 | 2.37 | 1.54 |
Filing Date Shares Outstanding | 1,403 | 1,403 | 1,403 | 1,403 | 1,403 | 1,403 |
Total Common Shares Outstanding | 1,403 | 1,403 | 1,403 | 1,403 | 1,403 | 1,403 |
Working Capital | 1,806 | 1,836 | 2,488 | 3,589 | 5,800 | 3,464 |
Book Value Per Share | 5.00 | 5.09 | 5.61 | 6.33 | 8.05 | 5.24 |
Tangible Book Value | 6,603 | 6,719 | 7,307 | 8,601 | 11,097 | 7,236 |
Tangible Book Value Per Share | 4.70 | 4.79 | 5.21 | 6.13 | 7.91 | 5.16 |
Buildings | 1,139 | 1,139 | 807.22 | 766.64 | 618.81 | 293.09 |
Machinery | 1,031 | 1,032 | 1,141 | 1,155 | 1,017 | 591.94 |
Construction In Progress | 321 | 311.71 | 776.1 | 727.35 | 576.63 | 210.65 |